Page 25 - Pfizer
UK regulator begins reviewing Pfizer-BioNTech coronavirus vaccine data
The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population, with the majority of doses anticipated in the first half of next year
 "UK regulator begins reviewing Pfizer-BioNTech coronavirus vaccine data")
Astra-Oxford Covid-19 vaccine works but doses could be in short supply
Pfizer and Moderna may have an initial advantage in dealing with manufacturing challenges, as their novel messenger RNA technology can be scaled up.
 "Astra-Oxford Covid-19 vaccine works but doses could be in short supply")
Pfizer Covid-19 vaccine could get UK approval this week, says report
Britain formally asked its medical regulator, the MHRA, last week to assess the suitability of the Pfizer-BioNTech vaccine
Russia's Covid-19 vaccine price to be lower than those of Pfizer, Moderna
The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of US drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account
 "Russia's Covid-19 vaccine price to be lower than those of Pfizer, Moderna")
India to Brazil, Astra-Oxford vaccine is key to many nations' Covid plan
The Astra vaccine costs a fraction of the price set by Pfizer; it should be easier to deploy far and wide than other shots.
 "India to Brazil, Astra-Oxford vaccine is key to many nations' Covid plan")
Pfizer, BioNTech seek emergency use of coronavirus shots in US
Pfizer asked US regulators to allow emergency use of its COVID vaccine, starting clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic
Pfizer seeking emergency use of its Covid-19 vaccine in US
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95% effective at preventing Covid-19
 "Pfizer seeking emergency use of its Covid-19 vaccine in US")
How sophisticated mRNA vaccines from Pfizer, Moderna are and how they work?
Pfizer-BioNTech vaccine candidate, BNT162b2, was 90% effective in preventing infection during the phase 3 clinical trial, which enrolled 43,538 participants, with 30% in U.S. and 42% abroad
 "How sophisticated mRNA vaccines from Pfizer, Moderna are and how they work?")
World Coronavirus Dispatch: Rapid vaccine production the real challenge
Covid-19 shakes up world's most expensive cities, how four Canadian provinces have protected their people, Italy runs short of ICU staff and other pandemic-related news across the globe
 "World Coronavirus Dispatch: Rapid vaccine production the real challenge")
 "Covid vaccine with no 'serious side-effects', but India faces cold-reality")
Pfizer-BioNTech's Covid-19 vaccine deliveries may start before Christmas
(Reuters) - Pfizer Inc and BioNTech <22UAy.DE> could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday.
 "Pfizer-BioNTech's Covid-19 vaccine deliveries may start before Christmas")
Pfizer, Moderna Covid-19 vaccines may be authorised for use within weeks
States and territories are prepared to begin distributing the vaccines within 24 hours of receiving regulatory authorization
 "Pfizer, Moderna Covid-19 vaccines may be authorised for use within weeks")
Pfizer says it's communicating with President-elect Joe Biden's team
Castillo says Pfizer is 'communicating with both sides' during the transition
Pfizer-BioNTech vaccine deliveries could start 'before Christmas'
The success rate of the vaccine developed by U.S. firm Pfizer and Germany's BioNTech is the highest of any candidate in late-stage clinical trials so far, and experts said it was a significant achieve
 "Pfizer-BioNTech vaccine deliveries could start 'before Christmas'")
Pfizer ends vaccine trial with 95% success rate, to apply for approval soon
Pfizer and BioNTech said they plan to submit the data to other regulatory agencies around the world.
 "Pfizer ends vaccine trial with 95% success rate, to apply for approval soon")
Covid-19 vaccine unlikely before early or mid-2021: WHO Southeast Asia head
Even the front-runners among vaccine companies would take at least a few months to complete Phase-III trials and evaluate the efficacy and safety of individual vaccines
 "Covid-19 vaccine unlikely before early or mid-2021: WHO Southeast Asia head")
Pfizer, BioNTech plan regulatory filing as vaccine proves 95% effective
The companies said their vaccine protected people of all ages and ethnicities
World Coronavirus Dispatch: All of Switzerland's ICU beds are full
UK govt under lens for £17 bn Covid deals, new cases in Russia top 22,000 a day, six-day lockdown in South Australia, and other pandemic-related news across the globe
 "World Coronavirus Dispatch: All of Switzerland's ICU beds are full")
Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate
Federal health officials met with Pfizer representatives on as Brazil seeks to secure vaccine supplies
 "Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate")
Centre examining all possible storage facilities for Pfizer's Covid vaccine
The Union Health Ministry said that the central government is examining all possibilities to extend cold chain facilities in case Pfizer's Covid-19 vaccine needs to be procured
